logo
Plus   Neg
Share
Email

Santos 2018 Underlying Profit More Than Doubles

Santos Ltd. (STOSF.PK,SSLTY.PK,STO.AX) reported that its underlying profit after tax for 2018 more than doubled to US$727 million from US$318 million in the prior year.

Net profit after tax was US$630 million, compared to a loss US$360 million last year.

Product sales grew to US$3.660 billion from US$3.100 billion in the prior year.

The Board has resolved to pay a 2018 final dividend of US6.2 cents per share fully-franked, in line with the company's sustainable dividend policy which targets a range of 10% to 30% payout of free cash flow.

The final dividend will be paid on 28 March 2019 to registered shareholders as at the record date of 27 February 2019.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration granted emergency use authorization (EUA) for the first and only clinical T cell-based test for patients to detect the unique T-cell signature specific to SARS-CoV-2, the virus that causes COVID-19. The test confirms recent or prior COVID-19 infection. Developed by Adaptive Biotechnologies, T-Detect COVID Test is a next generation sequencing based (NGS) test. AstraZeneca's one batch of Covid vaccine has been suspended by Austrian health authorities following reports of a death and an illness after receiving vaccination, reports said. The issues were reported in the district clinic of Zwettl in Lower Austria province. The Federal Office for Safety in Health Care in the country said the remaining stocks of the affected AstraZeneca/Oxford Covid-19 vaccine DuPont (DD) announced Monday that it has agreed to acquire Laird Performance Materials from with private equity firm Advent International for $2.3 billion. The company will use existing cash balances for the acquisition. The transaction is expected to close in the third quarter of 2021, subject to regulatory...
RELATED NEWS
Follow RTT